Perspectives on Adverse Reaction Rates Associated with the Use of High Osmolar Ionic and Low Osmolar Nonionic Contrast Media

1. Katayama, H. and the Japanese Committee on the Safety of Contrast Media. Unpublished. Clinical survey on adverse reactions of iodinated contrast media: Final report.

2. Katayama, H. , Yamaguchi, K. , Kazuka, T. , Takeshima, T. , Seez, P. , and Matsuura, K. (1990). Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175, 621–628.

3. Palmer, F. J. (1988). The RACR survey of contrast media reactions. A preliminary report. Australas. Radiol. 32, 8–11.

4. Witten, D.M. , Hirsch, F.D. , and Hartman, G.W. (1973). Acute reactions to urographic contrast medium. Am. J. Roentgenol. 119, 832–840.

5. Shehadi, W.H. (1975). Adverse reaction to intravenously administered contrast media. A comprehensive study based on a prospective survey. Am. J. Radiol. 124, 145.

6. Ansell, G. , Tweedie, M.C.K. , West, C.R. , Price Evans, D.A. , and Couch, L. (1980). The current status of reactions to intravenous contrast media. Invest. Radiol. 15, 532–539.

7. Shehadi, W.H. , and Toniolo, G. (1980). Adverse reactions to contrast media. Radiology 137, 299–302.

8. Schrott, K.M. , Behrends, B. , Clauss, W. , Kaufmann, J. , and Lehnert, J. (1986). Iohexol in excretory urography: Results of the drug monitoring programme. Forsch. Med. 104, 153–156.

9. Rothman, K.J. (1986). Modern Epidemiology. Boston: Little, Brown & Company.

10. Wolf, G.L. (1983). Adult peripheral angiography: Results from four North American randomized clinical trials of ionic media versus iohexol. Acta. Radiol. 366(Suppl), 166–170.

11. Bashore, T.M. , Mark, D.B. , Davidson, C. , Kisslo, K. , Skelton, T.N. , and Pryor, D. (1987). Iopamidol use in the cardiac catheterization laboratory: Initial experience with 1750 patients. Diagn. Imag. 9(suppl 4/2), 19–22.

12. Del Favero, C. (1988). Comparison of side effects of ionic and nonionic contrast media. Riv. Neuroradiol. 1, 161–164.

13. Wolf, G. L. , Arenson, R.L. , and Cross, A.P. (1989). A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: Comparison of adverse effects. Am. J. Roentgenol. 15, 939.

14. Levorstad, K. , Vatne, K. , Brodahl, U. , Laake, B. , Simonsen, S. , and Aakhus, T. (1989). Safety of the nonionic contrast medium Omnipaque in coronary angiography. Cardiovasc. Intervent. Radiol. 12, 98–100.

15. Nelson, M. , Bartlett, R.J.V. , and Lamb, J.T. (1989). Seizures after intravenous contrast media for cranial computed tomography. J. Neurol. Neurosurg. Psychiatry 52, 1170–1175.

16. Katayama, H. and the Japanese Committee on the Safety of Contrast Media. (1988). Report of the Japanese Committee on the Safety of Contrast Media. Poster session presented at the Radiological Society of North America meeting.

17. Felder, E. (1984). Iopamidol toxicology. Invest. Radiol. 19, S168–S170.

18. Morris, T. W. , Hayakawa, K. , Sahler, L.G. , and Ekholm, S. (1986). Incidence of fibrillation with isotonic contrast media for intra-arterial coronary digital substraction angiography. Diagn. Imag. Clin. Med. 55, 109:113.

19. Piao, Z. E. , Hwang, M.H. , Murdock, D.K. , Loeb, H.S. , and Scanlon, P.J. (1990). Effects of ionic and nonionic contrast media on bradyarrhythmia during coronary angiography: A comparison of Renografin-76, Hypaque-76 and Isovue-370. J. Lab. Clin. Med. 115, 122–128.

20. Lanzer, P. , Dean, P.B. , Lipton, M.J. , Sievers, R.S. , Botvinick, E. , and Higgins, C.B. (1985). Effects of intravenous administration of a new nonionic dimeric contrast media on the coronary circulation: Comparison of monomelic ionic and nonionic. Invest. Radiol. 20, 746–750.

21. Yamashita, K. , Hayakawa, K. , Tanaka, M. , and Konishi, J. (1988). Cardiovascular responses following the intracarotid injection of ionic and nonionic contrast media compared with various mannitol solutions. Invest. Radiol. 23, 680–686.

22. Higgins, C. B. , Gerber, K.H. , Mattrey, R.F. , and Slutsky, R.A. (1982). Evaluation of hemodynamic effects of intravenous administration of ionic and nonionic contrast materials. Radiology 142, 681–686.

23. Higgins, C. B. (1980). Direct myocardial effects of intracoronary administration of new contrast materials with low osmolality. Invest. Radiol. 15, 363–370.

24. Newell, J. D. , Higgins, C.B. , Kelley, M.J. , Green, C.E. , Schmidt, W.S. , and Haigler, F. (1980). The influence of hyperosmolity on left ventricular contractile state: Disparate effects of nonionic and ionic solutions. Invest. Radiol. 15, 363–370.

25. Morris, T. W. , Francis, M. , and Fischer, H.W. (1979). A comparison of the cardiovascular responses to carotid injections of ionic and nonionic contrast media. Invest. Radiol. 14, 217–223.

26. Higgins, C. B. , Kuber, M. , and Slutsky, R.A. (1983). Interaction between verapamil and contrast media in coronary arteriography: Comparison of standard ionic and nonionic media. Circulation 68, 628–635.

27. Pinto, I.M.F. , Kou, W.H. , McGillem, M.J. , DeBoe, S.F. , Mickelson, J.K. , and Mancini, G.B.J. (1989). Induction of ventricular arrhythmia by high and low osmolality ionic and nonionic contrast media. Am. Heart J. 117, 1283–1287.

28. Friedman, H. Z. , DeBoe, S.F. , McGillem, M.J. , and Mancini, G.B.J. (1987). Immediate effects of graded ionic and nonionic contrast injection on coronary blood flow and myocardial function. Invest. Radiol. 22, 722–727.

29. Gerber, K. H. , Higgins, C.B. , Yuh, Y.S. , and Koziol, J.A. (1982). Regional myocardial hemodynamics and metabolic effects of ionic and nonionic contrast media in normal and ischemic states. Circulation 65, 1307–1314.

30. Slutsky, R. A. , and Strich, G. (1985). Extravascular lung water: Effects of intravenous ionic and nonionic (Iopamidol) radiology contrast media during ischemia. Radiology 155, 11–14.

31. Peck, W. W. , Slutsky, R.A. , Hackney, R.B. , Mancini, G.B.J. , and Higgins, C.B. (1983). Effects of contrast media on pulmonary hemodynamics: Comparison of ionic and nonionic agents. Radiology 149, 371–374.

32. Higgins, C. B. (1984). Overview and methods used for the study of cardiovascular actions of contrast materials. Invest. Radiol. 15(Suppl), S188–S193.

33. Higgins, C. B. , Kuber, M. , and Slutsky, R.A. (1983). Interaction between verapamil and contrast media in coronary arteriography: Comparison of standard ionic and nonionic media. Circulation 68, 628–635.

34. Higgins, C. B. , and Schmidt, W. (1978). Alterations in calcium levels of coronary sinus blood during coronary arteriography in the dog. Circulation 58, 512–519. (Reported in Higgins et al. 1980).

35. Dawson, P. (1985). Chemotoxicity of contrast media and clinical adverse effects: Areview. Invest. Radiol. 20, S84-S91.

36. Dawson, P. (1988). Nonionic contrast agents and coagulation. Invest. Radiol. 23(Suppl 2), S310–317.

37. Laerum, F. (1987). Cytotoxic effects of six angiographic contrast media on human endothelium in culture. Acta. Radiol. 28, 99–105.

38. Velaj, R. , Drayer, B. , Albright, R. , and Fram, E. (1985). Comparative neurotoxicity of angiographic contrast media. Neurology 35, 1290–1298.

39. Aspelin, P. (1978). Effects of ionic and nonionic contrast media on morphology of human erythrocytes. Acta Radiol. 19, 675–687.

40. Raininko, R. , and Ylinen, S.L. (1987). Effect of ionic and nonionic contrast media on aggregation of red blood cells in vitro: A preliminary report. Acta Radiol. 28, 87–92.

41. Zucker, M. B. , and Mauss, E.A. (1988). Erythrocyte aggregation in iohexol and other nonionic media. Invest. Radiol. 23, 340–345.

42. Aspelin, P. , Schmid-SCHOENBIEN, S. , and Malotta, H. (1988). Do nonionic contrast media increase red cell aggregation and clot formation? Invest. Radiol. 23, S214.

43. Grabowski, E. F. (1988). Effects of contrast media on erythrocyte and platelet interactions with endothelial cell monolayers to flowing blood. Invest. Radiol. 23(Suppl. 2), S351–S358.

44. Kimball, J. P. , Sansone, V.J. , Diters, L.A. , and Wissel, Ps. (1988). Red blood aggregation vs blood clot formation in ionic and nonionic contrast media. Invest. Radiol. 23(Suppl. 2), S334–S339.

45. Hwang, M. H. , Piao, Z.E. , Murdock, D.K. , et al. (1989). The potential risk of thrombosis during coronary angiography using nonionic contrast media. Cath. Cardiovasc. Diagn. 16, 209–213.

46. Parvez, Z. , Moncada, R. , Messmore, H.L. , and Fareed, J. (1982). Ionic and nonionic contrast media interaction with anticoagulant drugs. Acta Radiol. 23, 401–404.

47. Ing, J. J. , Smith, D.C. , and Bull, B.S. (1989). Differing mechanisms of clotting inhibition by ionic and nonionic contrast agents. Radiology 172, 345–348.

48. Andes, W. A. (1988). Effects of contrast media on fibrinogen and factor VII. Invest. Radiol. 23(Suppl. 2), S346–S350.

49. Schulze, B. , and Beyer, H.K. (1989). Comparative assays of the chemotoxicity of iodinated radiographic contrast media based on impairment of fibrin antithrombin activity. Fortschr. Geb. Rontgenstr. Nuklearmed. Erganzung. 128, 21–23.

50. Kopko, P. M. , Smith, D.C. , and Bull, B.S. (1990). Thrombin generation in nonclottable mixtures of blood and nonionic contrast agents. Radiology 174, 459–461.

51. Corot, C. , Perrin, J.M. , Revel, D. , Belleville, J. , Amiel, M. , and Eloy, R. (1988). In vitro evaluation of iodinated contrast media on blood clotting. The radiological society of North America 74th Scientific Assembly and Annual Meeting. Chicago, IL.

52. Sw Anson, D.P. , Dick, T.J. , Simms, S.M. , and Thrall, J.H. (1985). Product selection criteriafor intravascular ionic contrast media. Clin. Pharm. 4, 527–538.

53. Bush, W. H. (1990). Treatment of systemic reactions to contrast media. Urology 35, 145–150.

54. Grainger, R. G. (1984). Low osmolar contrast media. Br. Med. J. 289, 144–145.

55. Lasser, E. C. (1984). Adverse systemic reactions to contrast media. In: Sovak. M. (ed.). Radiocontrast Agents. New York: Springer, pp. 525–532.

56. Lasser, E. C. , and Berry, C.C. (1989). Nonionic vs. ionic contrast media: What do the data tell us? Am. J. Roentgenol. 152, 945–946.

57. Hanley, P. C. , Holmes, D.R. Jr., Julstrud, P.R. , and Smith, H.C. (1986). Use of conventional and newer radiographic contrast agents in cardiac angiography. Prog. Cardiovasc. Dis. 28, 435–448.

58. Bettmann, M. A. (1986). The new contrast agents: A prospective. Cardiovasc. Intervent. Radiol. 9, 173–175.

59. Swanson, D. P. (1986). Evaluation of intravascular low-osmolality contrast agents. Clin. Pharm. 5, 877–891.

60. Spataro, R. F. (1988). New and old contrast agents: Pharmacology, tissue opacification and excretory urography. Urol. Radiol. 10, 2–5.

61. Wolf, G. L. (1986). Safer, more expensive iodinated contrast agents: How do we decide? Radiology 159, 557–558.

62. McClennan, B. L. (1987). Low-osmolality contrast media: Premises and promises. Radiology 162, 1–8.

63. Thompson, W. M. (1984). Excretory urography: Comparison of iopamidol and meglumine diatrizoate. Invest Radiol. 19, S229–S233.

64. Dawson, P. , Pittfield, J. , and Britton, J. (1983). Contrast media and bronchospasm: A study with iopamidol. Clin. Radiol. 34, 227–230.

65. Dawson, P. , Grainger, R.G. , and Pitfield, J. (1983). The new low-osmolar contrast media: A simple guide. Clin. Radiol. 34, 221–226.

66. Benamor, M. , Aten, E.M. , McElvany, K.D. , et al. (1989). Ioversol: Clinical safety summary. Invest. Radiol. 24 (Suppl. 1), 567–572.

67. Dahlstrom, K. , Shaw, D.D. , Clauss, W. , Andrew, E. , and Sveen, K. (1985). Summary of U.S. and European intravascular experience with iohexol based on the clinical trial program. Invest. Radiol. 20, S117–S121.

68. Dray, R. J. , Winfield, A.C. , Muhletaler, C.A. , and Kirchner, F.K. (1984). Advantages of nonionic contrast agents in adult urography. Urology 24, 297–299.

69. Drayer, B. P. , Vassallo, C. , Sudilovsky, A. , et al. (1983). A double-blind clinical trial of iopamidol versus metrizamide for lumbosacral myelography. J. Neurosurg. 58, 531–537.

70. Gertz, E. W. , Wisneski, J.A. , Chiu, D. , Akin, J.R. , and Hu, C. (1985). Clinical superiority of a new nonionic contrast agent (iopamidol) for cardiac angiography. JACC 5, 250–258.

71. Gordon, I. J. , Skoblar, R.S. , Chicatelli, P.D. , and Leon, J. (1984). A comparison of iohexol and Conray-60 in peripherai angiography. Am. J. Radiol. 142, 563–565.

72. Hirshfeld, J. W. , Wieland, J. , Davis, C. , et al. (1989). Hemodynamic and electrocardiographic effects of ioversol during cardiac angiography, comparison with iopamidol and diatrizoate. Invest. Radiol. 24, 138–144.

73. Jacobsson, B. F. , Jorulf, H. , Kalantar, M.S. , and Narasimham, D.L. (1988). Nonionic vs. ionic contrast media in intravenous urography clinical trial in 1000 consecutive patients. Radiology 167, 601–605.

74. Jensen, P. R. (1989). Reaction to contrast media in contrast enhanced computed tomography of the brain. Eur. J. Radiol. 9, 144–146.

75. Kido, D. K. , Potts, D.G. , Bryan, R.N. , et al. (1985). Iohexol cerebral angiography. Multicenter clinical trial. Invest. Radiol. 20, S55–S57.

76. Levorstad, K. , Simonsen, S. , and Jervell, J. (1983). Tolerability and usefulness of iohexol in cardioangiography. II. A double blind comparison with metrizoate. Acta Radiol. 366(Suppl.), 101–110.

77. McCullough, M. , Da Vies, P. , and Richardson, R. (1989). A large trial of intravenous Conray 325 and Niopam 300 to assess immediate and delayed reactions. Br. J. Radiol. 62, 260–265.

78. Orjavik, O. S. , Orning, O.M. , Skrede, M. , and Andrew, E. (1984). Iohexol in coronary angiography. Acta Radiol. Diagn. 25, 243–248.

79. Sage, M. R. , Bennese, G.T. , Perrett, L.V. , and Mansfield, J. (1981). Lumbar myelography today: Experience with Metrizamide, a water-soluble, nonionic contrast medium. Med. J. Aust. 1, 175–176.

80. Selin, K. , Emanuelsson, H. , and Renaa, T. (1983). Iohexol in coronary angiography. Acta Radiol. 366(Suppl.), 115–120.

81. Seyferth, W. , Dilbat, G. , and Zeitler, E. (1983). Efficacy and safety of digital subtraction angiography with special reference to contrast agents. Cardiovasc. Intervent. Radiol. 6, 265–270.

82. Vik-MO, H. , Rosland, G.A. , Folling, M. , and Danielsen, R. (1988). Hemodynamic and electrocardiographic consequences of high and low osmolality contrast agents for left ventricular angiography. Cathet. Cardiovasc. Diagn. 14, 143–149.

83. Rapaport, S. , Bookstein, J.J. , Higgins, C.B. , Carey, P.H. , Sovak, M. , and Lasser, E.C. (1982). Experience with metrizamide in patients with previous severe anaphylactoid reactions to ionic contrast agents. Radiology 143, 321–325.

84. Shehadi, W. H. (1982). Contrast media adverse reactions: Occurrence, recurrence and distribution patterns. Radiology 143, 11–17.

85. Fischer, H. W. , and Spataro, R.F. (1988). Use of low osmolality contrast media in patients with previous reactions. Invest. Radiol. 23(S1), S186–S188.

86. Gomes, A. S. , Lois, J.F. , Baker, J.D. , McGlade, C.T. , Bunnell, D.H. , and Hartzman, S. (1989). Acute renal dysfunction in high-risk patients after angiography: Comparison of ionic and nonionic contrast media. Radiology 170, 65–68.

87. Ansell, G. (1970). Adverse reactions to contrast agents: Scope of problems. Invest. Radiol. 5, 374–384.

88. Abrams, H. L. (1983). Complications of selective coronary arteriography. In: Abrams, H.L. (ed.). Abrams Angiography. Vascular and Interventional Radiology, 3rd ed., Vol. 1. Boston: Little, Brown, pp. 503–518. (Reported in Levorstad, 1989).

89. Adams, D. F. (1982). How safe is the coronary angiogram? Cardiovasc. Intervent. Radiol. 5, 168–173. (Reported in Levorstad, 1989).